Skip to content
Beacon

FBTFirst Trust NYSE Arca Biotechnology Index Fund

Grow my money20y track recordRanked #603 of 2,999 in this goal

Seeks investment results that correspond generally to the price and yield of the NYSE Arca Biotechnology Index.

By First Trust · Launched 2006

Annual Cost

0.55%

#2,921 of 5,861 · average

Fund Size

$2.8B

#622 of 5,861 · large

Return (1Y)Goal

+47.8%

Track Record

20 years

#319 of 5,861 · established

Performance

Total-return NAV · USD
Growth of $10,000
$13,277+32.8%

Total-return NAV, USD. Net of fund fees, before tax.

What's inside

How Beacon categorizes this fund

Asset class

Equity

Region

North america

Strategy

Index tracking

Sector

Health care

Focus

Biotech & Genomics

Index tracked

NYSE Arca Biotechnology Index

What it actually holds

By weight

Concentration

Top 10 holdings = 39.9% of fund✓ well diversified

Moderna Inc
5.3%
United Therapeutics Corporation
4.4%
Alkermes PLC
4.2%
Gilead Sciences Inc.
4.1%
Axsome Therapeutics Inc.
3.9%
Amgen Inc.
3.8%
Corcept Therapeutics Inc.
3.8%
Krystal Biotech Inc
3.5%
Biogen Inc
3.5%
Exelixis, Inc.
3.5%

Asset allocation

Stocks
99.9%
Cash
0.1%

By sector

Healthcare
100.0%

Risk profile

Last 12 months · Sharpe & Sortino need 3+ years
Volatility (1Y)
21.4%High

Year-on-year price swings

Max drawdown
-33.3%Severe

Worst peak-to-trough loss

Sharpe (3Y)
0.68Decent risk-adjusted returns
Sortino (3Y)
0.99Moderate downside risk

Listing

Exchange
NYSE Arca

Full fund details

Objective
Seeks investment results that correspond generally to the price and yield of the NYSE Arca Biotechnology Index.
Strategy
Invests at least 90% of net assets in securities that comprise the NYSE Arca Biotechnology Index using an indexing investment approach. The Index tracks 30 leading biotechnology companies, equally weighted, and includes companies with various market capitalizations listed on U.S. exchanges.
Inception date
June 19, 2006
Fund family
First Trust

What's next?

You've looked at FBT. Save it to your watchlist to weigh it against other funds, then turn your shortlist into a portfolio.

See other funds for this goal

Data updated on 2026-08-04